Post-Marketing Surveillance (PMS) in Regulatory Affairs: A Complete Guide 👤 Dr. Sornaraja Thasma | 🗓️ 24 March, 2026 | 📂 Regulatory Affairs Introduction Post-Marketing Surveillance (PMS) has become a critical pillar in regulatory affairs as pharmaceutical and medical device companies face increasing scrutiny from global health authorities. While clinical trials provide initial safety and efficacy...



